Latest Series C+ Funding Rounds
Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.
- Rounds
- 424 All time
- Disclosed funding
- $108.3B 381 disclosed amounts
- Median round
- $120M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| IM Inquis MedicalCompany profile Develops mechanical thrombectomy systems for venous thromboembolic disease Develops mechanical thrombectomy systems for venous thromboembolic disease | $75M | Series CSeries C+ | Healthtech | United States | Investors Undisclosed | |
| T TorqCompany profile Empowers enterprises to instantly and precisely detect and respond to security events at scale Empowers enterprises to instantly and precisely detect and respond to security events at scale | $140M | Series DSeries C+ | Cybersecurity | United States | Investors | |
| R Provides enterprise-grade infrastructure for stablecoin-powered payments | $250M | Series CSeries C+ | Fintech | United States | Investors | |
| b bit.bioCompany profile Creates functional, human-relevant cells and models for research, drug discovery, and development Creates functional, human-relevant cells and models for research, drug discovery, and development | $50M | Series CSeries C+ | Biotech | United Kingdom | Investors | |
| F FineHeartCompany profile Develops cardiology devices, including the fully implantable FlowMaker system. Develops cardiology devices, including the fully implantable FlowMaker system. | €83M | Series CSeries C+ | Healthtech | France | Investors | |
| LP Luxury PresenceCompany profile Luxury Presence provides an AI-based growth platform for real estate agents. Luxury Presence provides an AI-based growth platform for real estate agents. | $37M | Series CSeries C+ | Developer tools | United States | Investors | |
| C CyeraCompany profile Provides a data security and AI governance platform helping enterprises control what AI can see and do Provides a data security and AI governance platform helping enterprises control what AI can see and do | $400M | Series FSeries C+ | Cybersecurity | United States | Investors | |
| V Develops and manufactures insulin patch pump systems for diabetes management | $13M | Series DSeries C+ | Healthtech | Netherlands | Investors | |
| PM Parabilis MedicinesCompany profile Develops medicines targeting historically undruggable protein targets in cancer Develops medicines targeting historically undruggable protein targets in cancer | $305M | Series FSeries C+ | Biotech | United States | Investors Alderline GroupARCH Venture Partners +21Catalio Capital ManagementCormorant Asset ManagementFarallon Capital ManagementFidelity Management & Research CompanyForesite CapitalFrazier Life SciencesGeneral CatalystGV (Google Ventures)HBM HealthcareInvusJanus Henderson InvestorsMarshall WaceMilky Way InvestmentsNextech InvestRA Capital ManagementRock Springs CapitalSamsara BioCapitalSixty Degree CapitalSoleus CapitalT. Rowe Price AssociatesvenBio Partners | |
| RM Rakuten MedicalCompany profile Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment Develops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatment | $100M | Series FSeries C+ | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Andreessen Horowitz (a16z)
ASI, Labelbox, Valon
36rounds3led - 2Sequoia Capital
Whop, Blacksmith, Abby Care
32rounds3led - 3General Catalyst
Tractian, Legora, Modal Labs
29rounds0led - 4Lightspeed
Enveda, Snorkel AI, Profound
28rounds3led - 5Y Combinator (YC)
Tractian, Blacksmith, Jeeves
22rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.